Exicure, Inc. (XCUR)
Largest Insider Buys in Sector
XCUR Stock Price History Chart
XCUR Stock Performance
About Exicure, Inc.
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Insider Activity of Exicure, Inc.
Over the last 12 months, insiders at Exicure, Inc. have bought $0 and sold $4.49M worth of Exicure, Inc. stock.
On average, over the past 5 years, insiders at Exicure, Inc. have bought $3.56M and sold $1.62M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,400,000 shares for transaction amount of $5.44M was made by CBI USA, Inc. (director) on 2022‑12‑15.
List of Insider Buy and Sell Transactions, Exicure, Inc.
| 2024-02-29 | Sale | DGP Co., Ltd. | 10 percent owner | 3.4M 74.1245% | $1.32 | $4.49M | -27.96% | |
| 2022-12-15 | CBI USA, Inc. | director | 3.4M – | $1.60 | $5.44M | +23.08% | ||
| 2022-05-19 | Muralidhar Bali | 1.47M 1.7441% | $0.19 | $285,151 | -61.43% | |||
| 2021-12-21 | Sale | Gates Frontier, LLC | 10 percent owner | 1.27M 1.423% | $0.24 | $303,200 | -53.10% | |
| 2021-08-27 | Papadimas Elias D. | Chief Accounting Officer | 10,000 0.0114% | $1.38 | $13,800 | -86.06% | ||
| 2020-06-12 | Sale | Mirkin Chad A. | 10,195 0.012% | $2.83 | $28,852 | -27.64% | ||
| 2020-06-12 | Sale | AURASENSE LLC | 10 percent owner | 10,195 0.012% | $2.83 | $28,852 | -27.64% | |
| 2020-03-13 | WALT DAVID R | director | 291,066 0.3405% | $1.21 | $352,859 | +77.31% | ||
| 2020-03-12 | SNYDER DAVID S | Chief Financial Officer | 18,248 0.0224% | $1.40 | $25,591 | +60.69% | ||
| 2020-03-12 | Mirkin Chad A. | 15,000 0.0191% | $1.45 | $21,750 | +60.69% | |||
| 2019-12-19 | Muralidhar Bali | director | 727,000 0.8229% | $2.75 | $2M | -22.94% | ||
| 2019-08-02 | WALT DAVID R | director | 1M 1.0487% | $2.00 | $2M | -15.25% | ||
| 2019-08-02 | Venkatesan Jay | director | 250,000 0.2622% | $2.00 | $500,000 | -15.25% | ||
| 2019-08-02 | Mirkin Chad A. | 25,000 0.0262% | $2.00 | $50,000 | -15.25% | |||
| 2019-03-22 | Mirkin Chad A. | 500 0.0012% | $2.30 | $1,150 | +15.56% | |||
| 2019-03-21 | Mirkin Chad A. | 1,000 0.0023% | $2.43 | $2,430 | +10.64% | |||
| 2019-03-19 | Giljohann David A | Chief Executive Officer | 7,000 0.0158% | $2.40 | $16,800 | +8.33% | ||
| 2019-03-18 | Mirkin Chad A. | 1,000 0.0023% | $2.40 | $2,400 | +11.11% | |||
| 2019-03-13 | Mirkin Chad A. | 2,200 0.005% | $2.50 | $5,500 | +4.00% | |||
| 2017-09-26 | Tompkins Mark N. | 333,334 0.8176% | $3.00 | $1M |
Insider Historical Profitability
| DGP Co., Ltd. | 10 percent owner | 0 0% | $0.31 | 0 | 1 | |
| AURASENSE LLC | 10 percent owner | 11257629 130.1714% | $0.31 | 0 | 1 | |
| Mirkin Chad A. | 11257629 130.1714% | $0.31 | 6 | 1 | +16.55% | |
| Muralidhar Bali | 8449126 97.6968% | $0.31 | 2 | 0 | <0.0001% | |
| Gates Frontier, LLC | 10 percent owner | 5064703 58.5629% | $0.31 | 0 | 1 | |
| WALT DAVID R | director | 2058777 23.8055% | $0.31 | 3 | 0 | +31.03% |
| Tompkins Mark N. | 1825667 21.1101% | $0.31 | 2 | 0 | ||
| Venkatesan Jay | director | 302234 3.4947% | $0.31 | 2 | 0 | <0.0001% |
| Jacobs Ian Seth | President, Secretary, CEO, CFO | 65000 0.7516% | $0.31 | 0 | 1 | |
| Giljohann David A | Chief Executive Officer | 23666 0.2736% | $0.31 | 2 | 0 | +8.33% |
| SNYDER DAVID S | Chief Financial Officer | 18248 0.211% | $0.31 | 1 | 0 | +60.69% |
| Papadimas Elias D. | Chief Accounting Officer | 10000 0.1156% | $0.31 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
No records found… | |||||||